Efficacy and safety of bevacizumab in Turkish patients with metastatic and recurrent cervical cancer

OBJECTIVE: To evaluate the efficacy of bevacizumab a monoclonal, antivascular endothelial growth factor antibody in combination with cytotoxic chemotherapy in Turkish patients with recurrent and metastatic cervical cancer. MATERIALS AND METHODS: Data of 64 patients with metastatic or recurrent cervi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ercelep, Özlem, Tataroğlu, Deniz, Özçelik, Melike, Sürmeli, Heves, Değirmenci, Mustafa, İnanç, Mevlüde, Aliustaoğlu, Mehmet, Gümüş, Mahmut
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2020
Materias:
Clinical Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406906/
https://www.ncbi.nlm.nih.gov/pubmed/32850187
http://dx.doi.org/10.4274/tjod.galenos.2020.90699

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406906/
https://www.ncbi.nlm.nih.gov/pubmed/32850187
http://dx.doi.org/10.4274/tjod.galenos.2020.90699

Ejemplares similares